Vaccines
News
COVID-19 may discourage pediatric flu vaccination
Approximately one-third of parents whose children received no flu vaccine last year said the pandemic made them less likely to vaccinate their...
News
Shingrix effective in older adults with preexisting immune-mediated disorders
The most common immune-mediated disorders in two phase 3 clinical trials of the vaccine were psoriasis, spondyloarthropathy, rheumatoid arthritis...
News
HPV vaccine shown to substantially reduce cervical cancer risk
A review of more than 1 million girls/women vaccinated in 2006-2017 shows a substantial reduction in the risk for invasive cervical cancer.
Latest News
J&J’s one-shot COVID-19 vaccine advances to phase 3 testing
J&J’s vaccine is unusual in that it will be tested based on a single dose, while other advanced candidates have been tested in two-dose...
Latest News
Three major COVID vaccine developers release detailed trial protocols
Typically, manufacturers guard the specifics of preclinical vaccine trials. This rare move follows calls for greater transparency.
News
Dangers behind antimaskers and antivaxxers: How to combat both
Just as antivaxxers work to swing the opinion of the vaccine-hesitant, anti-maskers are vying with public health advocates for the support of the...
Conference Coverage
COVID-19 vaccine supply will be limited at first, ACIP says
The working group expects that from 15 to 45 million doses of vaccine will be available by the end of December, depending on which vaccine is...
Opinion
Action and awareness are needed to increase immunization rates
There is much work to be done to catch up with vaccinations missed because of the pandemic.
Opinion
Are you SARS-CoV-2 vaccine hesitant?
How do you feel about the potential SARS-CoV-2 vaccine? Are you going to roll up your sleeve as soon as the vaccine becomes available in your...
Latest News
Oxford coronavirus vaccine ‘triggers immune response’
The candidate vaccine provoked an antibody response within 28 days.